Rabbit syndrome due to olanzapine;Rabbit-syndrom unter olanzapineinnahme

Psychiatrische Praxis

Volumn 32, Issue 4, 2005, Pages 202-204

  Sabolek, Michael ^a   Bayerle, Maria ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE;

AGED; ARTICLE; BIPOLAR DISORDER; CASE REPORT; DYSKINESIA; EXTRAPYRAMIDAL SYNDROME; HUMAN; PSYCHOSIS; RABBIT SYNDROME;

AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; NEUROLOGIC EXAMINATION; SYNDROME;

EID: 18944398394     PISSN: 03034259     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-834759     Document Type: Article

References (26)

1. Villneuve A. The rabbit syndrome: a peculiar extrapyramidal reaction. Can Psychiatry Assoc J 1972; 17: 69-72
2. Yassa R, Lal S. Prevalence of the rabbit syndrome. Am J Psychiatry 1986; 143: 656-657
3. Chiu HF, Lam LC, Chung DW, Wing YK, Schum PP. Prevalence of the rabbit syndrome in Hong Kong. J Nerv Ment Disord 1993; 181: 264-265
4. Hoy JS, Alexander BD. Rabbit Syndrome secondary to Risperidone. Pharmacotherapy 2002; 22: 513-515
5. Schwartz M, Beny A, Sharf B. Risperidone-induced rabbit syndrome. Br J Psychiatry 1998; 173: 267-268
6. Levin T, Heresco-Levy U. Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic. Eur Neuropsychopharm 1999; 9: 137-139
7. Mendhekar DN. Aripiprazole-induced rabbit syndrome. Austr New Zea J Psychiatry 2004; 38: 561
8. Durst R, Katz G, Zislin J, Raskin S, Kalman I. Rabbit syndrome treated with olanzapine. Br J Psychiatry 2000; 176: 193
9. Fornazzari L, Ichise M, Remington G, Smith I. Rabbit syndrome, antidepressant use, and cerebral perfusion SPECT scan findings. J Psychiatry Neurosci 1991; 16: 227-229
10. Schwartz M, Hocherman S. Antipschotic-induced rabbit syndrome: epidemiology, management and pathophysiology. CNS Drugs 2004; 18: 213-220
11. Nishimura K, Tuska M, Horikawa N. Withdrawal-emergent rabbit syndrome during dose reduction of risperodone. Eur Neuropsychopharmacol 2001; 11: 323-324
12. Kamijo Y, Soma K, Fukuda M, Asari Y, Ohwada T. Rabbit syndrome following phenol ingestion. J Toxicol Clin Toxicol 1999; 37: 509-511
13. Villeneuve A, Lajeunesse C. Clinical aspects of tardive dyskinesias induced by neuoleptics. Encephale 1988; 14: S209-214
14. Goetz CG, Blasucci LM, Leurgans S, Pappert EJ. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patient. Neurology 2000; 55: 789-794
15. Marsh L, Lyketsos C, Reich SC. Olanzapine for the treatment of psychosis with parkinson's disease and dementia. Psychosomatics 2001; 42: 477-481
16. Molho E, Factor S. Worsening of motor features of Parkinson's disease with olanzapine. Mov Disord 1998; 13: 256
17. Jemenez-Jemenez F, Tallo-Baranco O, Pareva O. Olanzapine can worsen parkinsonism. Neurology 1998; 50: 1183-1184
18. Ciudad A, Montes JM, Olivares JM, Gomez JC. Safety and tolerability of olanzapine compared with other antipsychotics in the treatment of elderly patients with schizophrenia: a naturalistic study. Eur Psychiatry 2004; 19: 358-65
19. Kopf A, Köster J, Schulz A, Krömker H, Becker T. Life threatening neuroleptic malignant syndrome due to olanzapine. Psychiat Prax 2003; 30: 279-282
20. Mancini F, Tassorelli C, Martignoni E, Moglia A, Nappi G, Cristina S, Pacchetti C. Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. Clin Neuropharmacol 2004; 27: 33-37
21. Juncos JL, Roberts VJ, Evatt ML, Jewart RD, Wood CD, Potter LS, Yeung PP. Quetiapine improves psychotic symptoms and cognistion in Parkinson's disease. Mov Disord 2004; 19: 29-35
22. Fernandez HH, Trieschmann ME, Burke MA, Jacques C, Friedman JH. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients. Mov Disord 2003; 18: 510-514
23. Pollak P. Psychic disorders. Rev Neurol 2002; 158: S125-131
24. Reddy S, Factor SA, Molho ES, Feustel PJ. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia. Mov Disord 2002; 17: 676-681
25. Targum SD, Abbott JL. Efficacy of quetiapine in Parkinson's patients with psychosis. J Clin Psychopharmacol 2000; 20: 54-60
26. Sethi S, Bhargava SC. Clozapine-induced rabbit syndrome. J Clin Psychiatry 2003; 64: 219